Profile
Jon is an experienced litigator in complex civil litigation spanning commercial, antitrust, administrative, consumer protection, trade secrets, products liability, class actions and appeals.
He has represented and counseled clients in a wide range of industries, with a particular interest in pharmaceuticals and life sciences. Jon has deep experience with federal and state antitrust and consumer protection issues, including those at the intersection of antitrust, intellectual property and trade secrets.
Jon routinely provides clients with strategic counseling regarding business, antitrust, regulatory, and consumer protection issues to navigate issues before they develop into potential liabilities or litigation. Clients commend Jon’s ability to conceive novel approaches to intractable problems and to see around corners to strategic issues on the horizon.
He has been recognized by The Legal 500 United States in the category of Dispute Resolution: Appellate and as Tier 1 Washington, D.C. Elite in the category of Antitrust.
In addition to his client-focused work, Jon maintains an active pro bono practice with a significant focus on voting rights litigation and representing unaccompanied immigrant children.
Concentrations
- Complex litigation and class actions
- Antitrust litigation, investigations and counseling
- Life sciences litigation, counseling and strategy
- Commercial litigation and business risk
- Trade secrets
- Consumer protection investigations, litigation and risk mitigation
- Appeals
Áreas de Atuação
Experiência
- Lead counsel for a generic pharmaceutical manufacturer plaintiff in antitrust litigation against a brand manufacturer and supplier alleging an anticompetitive scheme to lock up the supply of the active pharmaceutical ingredient (API) for medication related to cardiovascular health and impede generic competitors.°
- Lead counsel for several generic pharmaceutical manufacturer plaintiffs in antitrust litigation against a competitor alleging an anticompetitive scheme to foreclose the available supply of the API for medication related to female infertility and impede generic competition.°
- Provided ongoing antitrust counseling and representation to various pharmaceutical manufacturers regarding business decision-making relating to contracting, business arrangements, and litigation.°
- Lead counsel for a generic pharmaceutical manufacturer defending a nationwide antitrust class action brought by direct and indirect purchasers of a hypertension medication challenging the so-called “reverse payment” settlement of Hatch-Waxman patent litigation.°
- Lead counsel for a generic pharmaceutical manufacturer defending a nationwide antitrust class action brought by direct and indirect purchasers of an antidepressant medication challenging the so-called “reverse payment” settlement of Hatch-Waxman patent litigation.°
- Lead counsel for a generic pharmaceutical manufacturer defending a nationwide antitrust class action brought by direct and indirect purchasers of a blockbuster cholesterol medication challenging the so-called “reverse payment” settlement of Hatch-Waxman patent litigation.°
- Counseled multiple generic pharmaceutical manufacturers in various suits defending several nationwide antitrust class actions brought by direct and indirect purchasers of other drug products challenging the so-called “reverse payment” settlement of Hatch-Waxman patent litigation.°
- Lead counsel for a large national grocery and pharmacy chain defending multiple pharmaceutical products liability class actions and dozens of individual cases in a multidistrict litigation (MDL) alleging personal injuries and economic losses purportedly due to nitrosamine contamination of blood pressure and hypertension medications.°
- Lead counsel for a generic pharmaceutical manufacturer defending complex trade secrets and breach of contract litigation concerning microsphere injectable products.°
- Lead counsel for an international dietary supplements manufacturer in product advertising disputes before the National Advertising Division (NAD) of the Better Business Bureau (BBB).°
- Counseled an international medical device manufacturer in connection with U.S. regulatory and commercial compliance.°
- Counseled the pharmaceutical trade association in a successful constitutional challenge to the Maryland state drug pricing law.°
- Counseled the pharmaceutical trade association in a constitutional challenge to the New York state drug pricing law.°
- Counseled the Securities Investor Protection Corporation (SIPC) in the first-ever action brought against it by the Securities and Exchange Commission in federal court in the District of Columbia.°
- Counseled a major financial institution in litigation relating to the Chapter 11 reorganization of its subsidiary relating to residential mortgages.°
- Counseled an owner and operator of an extensive portfolio of extended-stay and select-service hotels in a contested matter arising from its Chapter 11 reorganization.°
- Counseled a major communications company in post-confirmation bankruptcy litigation.°
°The above representations were handled by Mr. Janow prior to his joining Greenberg Traurig, LLP.
- Intern, Hon. Rosemary M. Collyer, U.S. District Court for the District of Columbia, 2006
Reconhecimento & Liderança
- Listed, The Legal 500 United States, Dispute Resolution: Appellate
- Listed, The Legal 500 Washington, DC Elite: Antitrust Tier 1
- Member, American Bar Association
Credenciais
-
J.D., with Highest Honors, The George Washington University Law School
- Order of the Coif
- Production Editor, The George Washington Law Review
- B.A., magna cum laude, University of Maryland
- U.S. Court of Appeals for the Sixth Circuit, 2009-2010
- U.S. District Court for the District of Columbia, 2008-2009
- District of Columbia
- Connecticut
- New York